How to Use GMP Without Getting Burned
Eight chapters have built your GMP knowledge: what it is, how it forms, how accurate it is, when it lies, and its legal status. This chapter converts all of that into a practical decision framework — how to actually use GMP in your IPO investing process.
The Core Principle: GMP is One Input, Not The Answer
This bears repeating because it is the central error most investors make. GMP is a sentiment indicator — valuable, but not decisive. Used in isolation, it leads to poor decisions. Used as one signal among several, it genuinely improves decision-making.
The analogy: a weather forecast is one input when deciding whether to carry an umbrella. It is valuable. But combining it with the actual sky condition, the time of year, and your specific plans is better than the forecast alone. GMP is the weather forecast of IPO investing.
Building Your GMP Assessment Framework
Before every IPO application decision, assess five signals:
Signal 1: GMP Level and Trend
Level: What is the current GMP as a percentage of issue price?
- Above 20%: Strong positive signal (tempered by other factors)
- 10–20%: Moderate positive signal
- 0–10%: Neutral to mildly positive
- Negative: Meaningful warning signal
Trend: More important than the level. Is GMP rising, stable, or falling during the subscription period?
- Rising GMP: Momentum building — market increasingly confident
- Stable GMP: Conviction at current level
- Falling GMP: Sentiment deteriorating — investigate why
A falling GMP is often more informative than the absolute level. If an IPO opened with ₹50 GMP and it has fallen to ₹20 by Day 3, something has changed — subscription data, market conditions, or new information. Dig before holding your application.
Signal 2: QIB Subscription
As established throughout this book, QIB subscription is the most reliable institutional signal. Use it as the primary cross-check against GMP.
GMP + Strong QIB (10x+): Both signals aligned — high credibility, proceed with conviction GMP + Moderate QIB (3–10x): Generally positive but tempered High GMP + Weak QIB (below 3x): Divergence warning — GMP may be retail/operator driven High GMP + No QIB (SME IPO): Treat GMP with significant scepticism
Signal 3: Market Conditions
Assess the broad market environment on listing day relative to when GMP was set:
Market stable/rising: GMP more likely to be accurate Market declined 1–2% since subscription: Buffer some GMP downward Market in correction (2%+ down): Discount GMP significantly
For 3-day IPOs (T+3 listing), the market gap between application and listing is short enough that this matters less than for IPOs with longer subscription-to-listing windows.
Signal 4: Fundamental Quality
Is the company fundamentally sound at the issue price?
- Strong fundamentals, fair valuation + positive GMP: High conviction application
- Strong fundamentals, expensive valuation + positive GMP: Proceed cautiously
- Weak fundamentals + high GMP: GMP is sentiment, not validation — apply with full awareness
Signal 5: OFS Composition
Large OFS components create listing-day selling supply that GMP does not account for. For every ₹1,000 crore of OFS, there are sellers entering the market on Day 1 with no lock-in and strong incentives to sell.
OFS below 40% of issue: GMP impact on listing is relatively clean OFS 40–70%: Monitor selling pressure risk OFS above 70% (especially by promoters): GMP is structurally challenged by supply
The GMP Decision Matrix
Combining the five signals:
| GMP Level | QIB Sub | Fundamentals | Decision |
|---|---|---|---|
| High (20%+) | Strong (10x+) | Good | Apply with conviction |
| High (20%+) | Strong (10x+) | Expensive | Apply, plan quick exit |
| High (20%+) | Weak (under 3x) | Good | Apply but widen confidence interval |
| High (20%+) | Weak (under 3x) | Poor | Avoid — GMP unreliable here |
| Moderate (10–20%) | Strong | Good | Apply with normal conviction |
| Moderate | Moderate | Average | Apply conservatively (1 lot retail) |
| Low (0–10%) | Any | Good | Fundamentals drive decision, not GMP |
| Negative | Any | Any | Reassess application; withdrawal likely appropriate |
The Application Modification Discipline
One of the most underused features of the IPO process: you can modify or withdraw your application before the IPO closes.
GMP monitoring during the subscription period enables dynamic decision-making:
Day 1: Apply (if initial analysis is positive) Day 2 evening: Check QIB subscription and updated GMP
- If both are strong → Hold application confidently
- If QIB is weak but GMP still high → Consider reducing lots or setting a mental stop
Day 3 morning: Final check before close
- If GMP has fallen sharply and QIB is disappointing → Withdraw
This active monitoring approach — treating your IPO application as a position that can be adjusted during the subscription period — significantly improves outcomes.
What To Do Post-Allotment With GMP Information
If you receive allotment, re-assess GMP on the day before listing:
GMP still strong and confirmed by subscription: Plan to hold through listing or sell at your pre-set target price above current GMP (listing day demand can exceed GMP)
GMP has fallen since your application: Reassess your original thesis. If fundamentals are good, hold. If this was a pure listing-gain play and GMP is now flat or negative, plan to exit quickly at listing.
Negative GMP day before listing: Make peace with a potential listing loss. Decide in advance whether you will hold (if you believe in the fundamentals) or sell (if you applied purely for listing gains). Do not improvise on listing day.